Cited by 598Mitochondrial Function and PathologyAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

The DOI matches its Crossref record.

Cytochrome oxidase deficiency in Alzheimer’s disease

Parker, William Davis, Filley, Christopher M., Parks, Janice K.·1990·Neurology

DOI 10.1212/wnl.40.8.1302

Open this paper in CoChat — free account

Abstract

We assayed cytochrome oxidase and other electron transport chain activities in platelet mitochondria isolated from patients with Alzheimer's disease (AD). Five of 6 patients had striking reductions of platelet cytochrome oxidase activity (patient mean, 83.72 +/- 82.99 nmol/min/mg; control mean, 167.14 +/- 36.21 nmol/min/mg; n = 8). Other electron transport chain catalytic activities were not significantly different than control values. AD may be a systemic illness, a primary defect in cytochrome oxidase may be pathogenically important in its production, and the mitochondrial genes encoding cytochrome oxidase subunits may be important in producing the defect.

Integrity signals

Registry

Crossref · 10.1212/wnl.40.8.1302

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 201–300 of 597

Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease
Mosconi, L., de Leon, M., Murray, J., E, L., Lu, J., Javier, E., McHugh, P., & Swerdlow, R. H. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110866 · Cited by 97
“Upon receipt, platelets were isolated by centrifugation and enriched mitochondrial fractions were prepared using previously described methods [13, 14].”
Mitochondrial Dysfunction in Idiopathic Parkinson Disease
Parker, W. D., & Swerdlow, R. H. (1998) · The American Journal of Human Genetics · doi:10.1086/301812 · Cited by 97
Self-citation
No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease
Ahlskog, J. E., Uitti, R. J., Low, P. A., Tyce, G. M., Nickander, K. K., Petersen, R. C., & Kokmen, E. (1995) · Movement Disorders · doi:10.1002/mds.870100507 · Cited by 90
Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling
Jadiya, P., Garbincius, J. F., & Elrod, J. W. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01224-4 · Cited by 94
Selective inactivation of redox-sensitive mitochondrial enzymes during cardiac reperfusion
Sadek, H. A., Humphries, K. M., Szweda, P. A., & Szweda, L. I. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00446-0 · Cited by 91
Use of Cytoplasmic Hybrid Cell Lines for Elucidating the Role of Mitochondrial Dysfunction in Alzheimer's Disease and Parkinson's Disease
Ghosh, S. S., Swerdlow, R. H., Miller, S. W., Sheeman, B., Parker, W. D., & DAVIS, R. E. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07825.x · Cited by 91
Self-citation
Entorhinal cortex of the human, monkey, and rat: Metabolic map as revealed by cytochrome oxidase
Hevner, R. F., & Wong‐Riley, M. T. T. (1992) · The Journal of Comparative Neurology · doi:10.1002/cne.903260310 · Cited by 91
Selective loss of synaptic proteins in Alzheimer's disease: Evidence for an increased severity with APOE ɛ4
Tannenberg, R. K., Scott, H. L., Tannenberg, A. E. G., & Dodd, P. R. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.05.004 · Cited by 89
Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
Butterfield, D. A., & Boyd-Kimball, D. (2020) · Antioxidants · doi:10.3390/antiox9090818 · Cited by 85
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Austad, S. N., Ballinger, S. W., Buford, T. W., Carter, C. S., Smith, D. L., Darley-Usmar, V. M., & Zhang, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.014 · Cited by 94
Platelets, a reliable source for peripheral Alzheimer’s disease biomarkers?
Veitinger, M., Varga, B., Guterres, S. B., & Zellner, M. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-65 · Cited by 88
Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells
Gasparini, L., Racchi, M., Benussi, L., Curti, D., Binetti, G., Bianchetti, A., Trabucchi, M., & Govoni, S. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00536-3 · Cited by 89
Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology
Turski, L., & Turski, W. A. (1993) · Cellular and Molecular Life Sciences · doi:10.1007/bf01929915 · Cited by 88
Cell death mechanisms: Cross-talk and role in disease
Zhivotovsky, B., & Orrenius, S. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.037 · Cited by 90
Physical exercise during exposure to 40-Hz light flicker improves cognitive functions in the 3xTg mouse model of Alzheimer’s disease
Park, S.-S., Park, H.-S., Kim, C., Kang, H., Kim, D., Baek, S., & Kim, T.-W. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00631-4 · Cited by 94
Ammonia and Alzheimer’s disease
Seiler, N. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00041-4 · Cited by 88
Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
Reddy, P. H. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.003 · Cited by 88
Insulin signalling in Alzheimer′s disease and diabetes: from epidemiology to molecular links
Ribé, E. M., & Lovestone, S. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12534 · Cited by 88
Nicotine protects rat brain mitochondria against experimental injuries
Cormier, A., Morin, C., Zini, R., Tillement, J. P., & Lagrue, G. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00041-8 · Cited by 86
Mitochondrial Abnormalities in Alzheimer’s Disease
Silva, D. F., Selfridge, J. E., Lu, J., E, L., Cardoso, S. M., & Swerdlow, R. H. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00003-9 · Cited by 86
Free radical theory of aging: Alzheimer’s disease pathogenesis
Harman, D. (1995) · AGE · doi:10.1007/bf02436085 · Cited by 87
Dimebon (Latrepirdine) Enhances Mitochondrial Function and Protects Neuronal Cells from Death
Zhang, S., Hedskog, L., Petersen, C. H., Winblad, B. G., & Ankarcrona, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100174 · Cited by 85
Cognitive decline: A vitamin B perspective
Mikkelsen, K., Stojanovska, L., Tangalakis, K., Bosevski, M., & Apostolopoulos, V. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.08.001 · Cited by 86
“It has been postulated that an increase in life expectancy in western cultures has coincided with an increase in the prevalence of cognitive impairments (dementia, AD etc), and perhaps this is less about disease process and more about the natural process of ageing [4].”
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes
Mosconi, L., Berti, V., Swerdlow, R. H., Pupi, A., Duara, R., & de Leon, M. (2010) · Human Genomics · doi:10.1186/1479-7364-4-3-170 · Cited by 85
Characterization of assembly intermediates of NADH: Ubiquinone oxidoreductase (complex I) accumulated in Neurospora mitochondria by gene disruption
Nehls, U., Friedrich, T., Schmiede, A., Ohnishi, T., & Weiss, H. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90519-p · Cited by 84
The mitochondrial hypothesis: Dysfunction, bioenergetic defects, and the metabolic link to Alzheimer's disease
Swerdlow, R. H. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.01.008 · Cited by 88
The multifaceted role of platelets in mediating brain function
Burnouf, T., & Walker, T. L. (2022) · Blood · doi:10.1182/blood.2022015970 · Cited by 86
Protective Effect of Isorhynchophylline Against β-Amyloid-Induced Neurotoxicity in PC12 Cells
Xian, Y., Lin, Z., Mao, Q., Ip, S., Su, Z., & Lai, X. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9763-5 · Cited by 84
A chronic Alzheimer’s model evoked by mitochondrial poison sodium azide for pharmacological investigations
Szabados, T., Dul, C., Majtényi, K., Hargitai, J., Pénzes, Z., & Urbanics, R. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.01.016 · Cited by 84
Brain Energy Metabolizing Enzymes in Alzheimer's Disease: α‐Ketoglutarate Dehydrogenase Complex and Cytochrome Oxidasea
Kish, S. J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48473.x · Cited by 83
Antioxidants in Down syndrome
Lott, I. T. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.010 · Cited by 86
Decreased Brain Protein Levels of Cytochrome Oxidase Subunits in Alzheimer's Disease and in Hereditary Spinocerebella Ataxia Disorders
Kish, S. J., Mastrogiacomo, F., Guttman, M., Furukawa, Y., Taanman, J., Dozic, S., Pandolfo, M., Lamarche, J. B., DiStefano, L. M., & Chang, L. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720700.x · Cited by 85
The protective role of plant biophenols in mechanisms of Alzheimer's disease
Omar, S. H., Scott, C., Hamlin, A. S., & Obied, H. K. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.016 · Cited by 84
Treating neurodegeneration by modifying mitochondria: potential solutions to a “complex” problem
Swerdlow, R. H. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1676 · Cited by 81
Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-β precursor protein (APP) levels in the aged dog
Studzinski, C. M., MacKay, W. A., Beckett, T. L., Henderson, S. T., Murphy, M. P., Sullivan, P. G., & Burnham, W. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.005 · Cited by 82
Alzheimer's Disease and Amyloid: Culprit or Coincidence?
Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 82
“Ab inhibits a-ketoglutarate dehydrogenase activity in isolated mitochondria (Casley et al., 2002), and deficiency of a-ketoglutarate dehydrogenase (Gibson et al., 1988) and cytochrome oxidase activities (Parker et al., 1990) has been found in the brain and other tissues in AD.”
Background
Dopamine modulates mitochondrial function in viable SH-SY5Y cells possibly via its interaction with complex I: Relevance to dopamine pathology in schizophrenia
Brenner-Lavie, H., Klein, E., Zuk, R., Gazawi, H., Ljubuncić, P., & Ben‐Shachar, D. (2007) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2007.10.006 · Cited by 79
Cytochrome Oxidase Deficiency in Alzheimer's Diseasea
Parker, W. D. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb00191.x · Cited by 79
Self-citation
The Alzheimer’s Disease Mitochondrial Cascade Hypothesis: A Current Overview
Swerdlow, R. H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221286 · Cited by 88
Maternal family history is associated with Alzheimer's disease biomarkers
Honea, R. A., Initiative, F. T. A. D. N., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120676 · Cited by 79
“Mitochondrial DNA is exclusively maternally inherited in humans, and may differ between persons with and without AD [34].”
Cell cycle and cell death in disease: past, present and future
Zhivotovsky, B., & Orrenius, S. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02282.x · Cited by 81
Cytochrome Oxidase Inhibition: A Novel Animal Model of Alzheimer's Disease
Bennett, M. C., Diamond, D. M., Stryker, S. L., Parks, J. K., & Parker, W. D. (1992) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099200500206 · Cited by 77
Self-citation
Electron transfer complex I defect in idiopathic dystonia
Benecke, R., Strümper, P., & Weiss, H. (1992) · Annals of Neurology · doi:10.1002/ana.410320512 · Cited by 77
Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes
Amir, R. E., den Veyver, I. B. V., Schultz, R., Malicki, D. M., Tran, C. Q., Dahle, E. J., Philippi, A., Tímár, L., Percy, A. K., Motil, K. J., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5 · Cited by 351
ET-GRU: using multi-layer gated recurrent units to identify electron transport proteins
Le, N. Q. K., Yapp, E. K. Y., & Yeh, H. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2972-5 · Cited by 75
Rapid Biomarker Screening of Alzheimer’s Disease by Interpretable Machine Learning and Graphene-Assisted Raman Spectroscopy
Wang, Z., Ye, J., Zhang, K., Li, D., Granzier-Nakajima, T., Ranasinghe, J. C., Xue, Y., Sharma, S., Biase, I., Terrones, M., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c00538 · Cited by 77
Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ɛ4 Carriers
Perkins, M., Wolf, A. B., Chavira, B., Shonebarger, D., Meckel, J. P., Leung, L., Ballina, L. E., Ly, S., Saini, A., Jones, T. B., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151205 · Cited by 79
“Here, mitochondrial oxidative metabolism is altered in young adult APOE4 carriers in a manner that is opposite to what is seen in the disease state.”
Result
Neuroprotective activity of acetyl‐L‐carnitine: Studies in vitro
Forloni, G., Angeretti, N., & Smiroldo, S. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370112 · Cited by 73
Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer’s disease
Leuner, K., Pantel, J., Frey, C., Schindowski, K., Schulz, K. L., Wegat, T., Maurer, K., Eckert, A., & Müller, W. E. G. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_27 · Cited by 74
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease
Mancuso, M., Filosto, M., Bosetti, F., Ceravolo, R., Rocchi, A., Tognoni, G., Manca, M. L., Solaini, G., Siciliano, G., & Murri, L. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00092-x · Cited by 73
Reduced VDAC1 Protects Against Alzheimer's Disease, Mitochondria, and Synaptic Deficiencies
Mańczak, M., Sheiko, T. V., Craigen, W. J., & Reddy, P. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130761 · Cited by 73
Genetic risk factors in Alzheimer's disease.
Tilley, L. A., Morgan, K., & Kalsheker, N. A. (1998) · Molecular Pathology · doi:10.1136/mp.51.6.293 · Cited by 72
Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism
Hroudová, J., Singh, N., Fišar, Z., & Ghosh, K. K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.084 · Cited by 71
Cytochrome c Oxidase and Its Role in Neurodegeneration and Neuroprotection
Arnold, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3573-0_13 · Cited by 77
Is Parkinson's disease a mitochondrial disorder?
Nakagawa-Hattori, Y., Yoshino, H., Kondo, T., Mizuno, Y., & Horai, S. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90205-y · Cited by 71
Exploring and exploiting the connection between mitochondria and the virulence of human pathogenic fungi
Verma, S., Shakya, V. P. S., & Idnurm, A. (2018) · Virulence · doi:10.1080/21505594.2017.1414133 · Cited by 67
Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study
Ben‐Shachar, D., Bonne, O. B., Chisin, R., Klein, E., Lester, H., Aharon‐Peretz, J., Yona, I., & Freedman, N. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.025 · Cited by 72
Loss of the Mitochondrial Fatty Acid β-Oxidation Protein Medium-Chain Acyl-Coenzyme A Dehydrogenase Disrupts Oxidative Phosphorylation Protein Complex Stability and Function
Lim, S. C., Tajika, M., Shimura, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18530-4 · Cited by 70
Role of platelets in neurodegenerative diseases: a universal pathophysiology
Behari, M., & Shrivastava, M. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2012.751534 · Cited by 68
Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine
Cardoso, S., Carvalho, C., Correia, S. C., Seiça, R. M. F., & Moreira, P. I. (2016) · Brain Pathology · doi:10.1111/bpa.12402 · Cited by 69
Alzheimer’s Disease Pathologic Cascades: Who Comes First, What Drives What
Swerdlow, R. H. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9272-9 · Cited by 69
Mitochondrial abnormalities in muscle and other aging cells: Classification, causes, and effects
DiMauro, S., Tanji, K., Bonilla, E., Pallotti, F., & Schon, E. A. (2002) · Muscle & Nerve · doi:10.1002/mus.10194 · Cited by 64
Mitochondrial medicine
Luft, R., & Landau, B. R. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01218.x · Cited by 66
Mitophagy and the Brain
Swerdlow, N., & Wilkins, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249661 · Cited by 66
“enzyme, COX (or complex IV), has reduced Vmax in AD brain, fibroblasts, and blood samples [128,131-142].”
Background
Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: a model of the membrane defect of Alzheimer's disease
Farber, S. A., Slack, B. E., & Blusztajn, J. K. (2000) · The FASEB Journal · doi:10.1096/fj.99-0853 · Cited by 63
Mitochondrial Metabolism in Major Neurological Diseases
Zhou, Z., Austin, G. L., Young, L. E. A., Johnson, L. A., & Sun, R. C. (2018) · Cells · doi:10.3390/cells7120229 · Cited by 67
“This included reductions in cytochrome oxidase (COX) activity in AD patients [88], and decreases in mitochondrial enzymes such as PDH, and other enzymes in the early part of the TCA cycle, such as isocitrate dehydrogenase and”
Background
Free radical theory of aging: A hypothesis on pathogenesis of senile dementia of the Alzheimer’s type
Harman, D. (1993) · AGE · doi:10.1007/bf02436127 · Cited by 63
“For example, the mutation(s) responsible for the depressed cytochrome oxidase of platelet mitochondria found in five out of a group of six Alzheimer's patients (13) and the point mutations in cedon 331 of mitochondrial NADH dehydrogenase subunit 2 (ND 2) detected in 10 of 19 Alzheimer's brains (106).”
Background
Impact of Tau on Neurovascular Pathology in Alzheimer's Disease
Canepa, E., & Fossati, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.573324 · Cited by 67
Activities of mitochondrial respiratory chain complexes in platelets of patients with Alzheimer's disease and depressive disorder
Fišar, Z., Hansíková, H., Křížová, J., Jirák, R., Kitzlerová, E., Zvěřová, M., Hroudová, J., Wenchich, L., Zeman, J., & Raboch, J. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.07.013 · Cited by 64
Mitochondrial Microheteroplasmy and a Theory of Aging and Age-Related Disease
Smigrodzki, R. M., & Khan, S. M. (2005) · Rejuvenation Research · doi:10.1089/rej.2005.8.172 · Cited by 62
Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging
de Lustig, E. S., Serra, J. A., Kohan, S., et al. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90062-4 · Cited by 63
Newly Developed Drugs for Alzheimer’s Disease in Relation to Energy Metabolism, Cholinergic and Monoaminergic Neurotransmission
Korábečný, J., Nepovimová, E., Cikánková, T., Špilovská, K., Vašková, L., Mezeiová, E., Kuča, K., & Hroudová, J. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2017.06.034 · Cited by 64
Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease
Atlante, A., Amadoro, G., Bobba, A., & Latina, V. (2020) · Cells · doi:10.3390/cells9112347 · Cited by 67
Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients
Wilkins, H., Koppel, S. J., Bothwell, R. J., Mahnken, J. D., Burns, J. M., & Swerdlow, R. H. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.010 · Cited by 61
“The AD COX deficit manifests across several tissues, including platelets [24].”
Background
Regional hypometabolism in the 3xTg mouse model of Alzheimer's disease
Adlimoghaddam, A., Snow, W. M., Stortz, G., Perez, C., Djordjevic, J., Goertzen, A. L., Ko, J. H., & Albensi, B. C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.008 · Cited by 61
Transitions in metabolic and immune systems from pre-menopause to post-menopause: implications for age-associated neurodegenerative diseases
Wang, Y., Mishra, A., & Brinton, R. D. (2020) · F1000Research · doi:10.12688/f1000research.21599.1 · Cited by 65
Incorporation of β-sitosterol into mitochondrial membrane enhances mitochondrial function by promoting inner mitochondrial membrane fluidity
Shi, C., Wu, F., & Xu, J. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9495-3 · Cited by 60
Mitochondrial Dysfunction and Stress Responses in Alzheimer’s Disease
Weidling, I. W., & Swerdlow, R. H. (2019) · Biology · doi:10.3390/biology8020039 · Cited by 59
“showed altered COX activity in AD platelets, later extending their findings to AD brain tissue [4,27].”
Background
Rethinking Alzheimer's Disease Therapy: Are Mitochondria the Key?
Ankarcrona, M., Mangialasche, F., & Winblad, B. G. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100327 · Cited by 60
“vulnerable neurons [32], brain glucose metabolism is decreased [33], and the activities of both tricarboxylic acid cycle enzymes [34] and cytochrome c oxidase are reduced [35–38].”
Background
The Frequency of Point Mutations in Mitochondrial DNA Is Elevated in the Alzheimer's Brain
Chang, S.-W., Zhang, D., Chung, H. D., & Zassenhaus, H. P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2885 · Cited by 58
Mitochondrial function in neurodegeneration and ageing
Schapira, A. H. V., & Cooper, J. A. D. (1992) · Mutation Research/DNAging · doi:10.1016/0921-8734(92)90018-k · Cited by 59
Regional brain effects of sodium azide treatment on cytochrome oxidase activity: a quantitative histochemical study
Cada, A. M., Gonzalez-Lima, F., Rose, G. M., & Bennett, M. C. (1995) · Metabolic Brain Disease · doi:10.1007/bf02109361 · Cited by 58
“Cytochrome oxidase has been shown to be more vulnerable to insult in Alzheimer's disease than are other enzymes of the respiratory chain (Parker et al., 1990; 1994a,b; Kish et al., 1992, Beal et al., 1993, Mecocci et al ., 1994, Mutisya et al., 1994).”
Background
DeepETC: A deep convolutional neural network architecture for investigating and classifying electron transport chain's complexes
Le, N. Q. K., Ho, Q., Yapp, E. K. Y., et al. (2019) · Neurocomputing · doi:10.1016/j.neucom.2019.09.070 · Cited by 58
Mitochondria, Cognitive Impairment, and Alzheimer's Disease
Mancuso, M., Calsolaro, V., Orsucci, D., Carlesi, C., Choub, A., Piazza, S., & Siciliano, G. (2009) · International Journal of Alzheimer s Disease · doi:10.4061/2009/951548 · Cited by 58
“…of mitochondrial dementia requires neuropsychological testing, cerebrospinal fluid investigations, visually-evoked potentials, EEG, brain CT and MRI scans, phosphorus or protonmagnetic resonance spectroscopy, SPECT, or positron emission tomography with fluorine 18-labeled deoxyglucose…”
Nuclear and mitochondrial DNA oxidation in Alzheimer's disease
Santos, R. X., Correia, S. C., Zhu, X., Lee, H.-G., Petersen, R. B., Nunomura, A., Smith, M. A., Perry, G., & Moreira, P. I. (2012) · Free Radical Research · doi:10.3109/10715762.2011.648188 · Cited by 57
Systems biology identifies preserved integrity but impaired metabolism of mitochondria due to a glycolytic defect in Alzheimer's disease neurons
Theurey, P., Connolly, N. M. C., Fortunati, I., Basso, E., Lauwen, S., Ferrante, C., Pinho, C. M., Joselin, A. P., Gioran, A., Bano, D., et al. (2019) · Aging Cell · doi:10.1111/acel.12924 · Cited by 57
Oxidative stress, antioxidants, aging and disease
Packer, L. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7337-6_1 · Cited by 56
Mitochondrial Cascade Hypothesis of Alzheimer's Disease: Myth or Reality?
Mancuso, M., Coppedè, F., Murri, L., & Siciliano, G. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1761 · Cited by 56
“Deficient COX activity has been reported by several authors in different brain regions (7, 71, 93, 116), as well as in platelets (83) and fibroblasts (99) of sAD patients.”
Mitochondrial Dysfunction in Neurodegenerative Disorders and Ageing
Turner, C., & Schapira, A. H. V. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1249-3_19 · Cited by 56
Mitochondria, Amyloid β, and Alzheimer′s Disease
Readnower, R. D., Sauerbeck, A. D., & Sullivan, P. G. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/104545 · Cited by 58
“The most documented reduction of mitochondrial enzyme activity in AD is the activity of complex IV [5, 21–23].”
Background
Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
Guo, J., Cheng, J., North, B. J., & Wei, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.07.001 · Cited by 55
Mitochondrial enzyme deficiencies in Down's syndrome
Prince, J. A., Jia, S., Båve, U., et al. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260938 · Cited by 54
Is a point mutation in the mitochondrial ND2 gene associated with alzheimer's disease?
Petruzzella, V., Chen, X., & Schon, E. A. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80834-4 · Cited by 53
Mitochondrial links between brain aging and Alzheimer’s disease
Wilkins, H., & Swerdlow, R. H. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00261-2 · Cited by 53
Quantitative Histochemistry of Cytochrome Oxidase Activity
Gonzalez-Lima, F., & Cada, A. M. (1998) · Springer eBooks · doi:10.1007/978-1-4757-9936-1_2 · Cited by 53
Mutations in mitochondrial‐encoded cytochrome c oxidase subunits I, II, and III genes detected in Alzheimer's disease using single‐strand conformation polymorphism
Hamblet, N. S., Ragland, B. D., Ali, M. A., Conyers, B., & Castora, F. J. (2005) · Electrophoresis · doi:10.1002/elps.200500420 · Cited by 53
Synergy between chronic corticosterone and sodium azide treatments in producing a spatial learning deficit and inhibiting cytochrome oxidase activity.
Bennett, M. C., Mlady, G. W., Fleshner, M., & Rose, G. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1330 · Cited by 53
Untitled work
(2000) · doi:10.1002/1097-4547(20000915)61:6
Self-citation
Mitochondrial function and Aβ in Alzheimer's disease postmortem brain
Troutwine, B. R., Strope, T. A., Franczak, E., Lysaker, C. R., Hamid, L., Mansel, C., Stopperan, J. A., Gouvion, C. M., Haeri, M., Swerdlow, R. H., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105781 · Cited by 51
“Mitochondrial-localized APP and γ-secretase lead to generation of Aβ within mitochondria (Del Prete et al., 2017; Devi and Anandatheerthavarada, 2010; Hansson Petersen et al., 2008; Pavlov et al., 2011).”
Background
Triad of Risk for Late Onset Alzheimer’s: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex
Wang, Y., & Brinton, R. D. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00232 · Cited by 52
“In the early 1990’s, reduced cytochrome c oxidase (complex IV) activity was observed in both platelets and postmortem AD brain Frontiers in Aging Neuroscience | www.frontiersin.org 3 October 2016 | Volume 8 | Article 232 (Parker et al., 1990, 1994).”
Background

Authors: Parker, W. D., Filley, C. M., & Parks, J. K.
Affiliations: University of Colorado Denver (US)
ORCID: Filley, Christopher M.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1990-08
Volume: 40
Issue: 8
Pages: 1302-1302
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.40.8.1302
OpenAlex: W1988731658
Cited by: 598
References: 0
Citations by year: 2026: 19 · 2025: 10 · 2024: 12 · 2023: 20 · 2022: 9 · 2021: 22 · 2020: 25 · 2019: 19 · 2018: 18 · 2017: 18 · 2016: 28 · 2015: 10 · 2014: 10 · 2013: 21 · 2012: 15
FWCI: 7.27
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (7r01ns025382-06)
National Institute of Neurological Disorders and Stroke (NS25382)
National Center for Research Resources (RR-69)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: cytochrome oxidase deficiency, Alzheimer's disease, platelet mitochondria, electron transport chain, mitochondrial dysfunction, systemic disease
MeSH terms: Aged, Alzheimer Disease, Blood Platelets, Electron Transport Complex IV, Electron Transport, Female, Humans, Kinetics, Male, Mitochondria, Reference Values, Cytochrome-c Oxidase Deficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cytochrome oxidase deficiency in Alzheimer’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks